PLRX earnings: a positive outcome, +11.6%

On March 1, 2022, Pliant Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +11.6% in the window around the event. It had already run -16.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.